Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preradiation Chemotherapy for Adult High-Risk Medulloblastoma (E4397)
NCT00003309Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- May 1999
- Primary completion
- Mar 2004
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, etoposide, cyclophosphamide and vincristine in medulloblastoma, primitive neuroectodermal tumor (PNET) and ependymoma, sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Complete and Partial Response Rate. Started May 1999; status: completed.
02
Drugs
cisplatinetoposidecyclophosphamidevincristine
03
Conditions
medulloblastomaprimitive neuroectodermal tumor (PNET)ependymoma
Beyond the preview
Go deeper on NCT00003309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003309.